# A Phase I Clinical Trial of an HPV Therapeutic Vaccine

> **NCT01653249** · PHASE1 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 52 (actual)

## Conditions studied

- Human Papillomavirus

## Interventions

- **BIOLOGICAL:** Vaccine consisting of four HPV-16 E6 peptides in combination with Candin®

## Key facts

- **NCT ID:** NCT01653249
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653249, "A Phase I Clinical Trial of an HPV Therapeutic Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01653249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*